CD BioSciences Launches Biological Biofilm Eradication Services for Biofilm Research
New York/US – September 10, 2026 Biofilm control strategies can target different stages of the biofilm lifecycle, including initial attachment, maturation, extracellular matrix development, and disruption of established biofilms. To support global academic and industrial researchers investigating biofilm formation mechanisms and mitigation strategies, CD BioSciences recently launched its comprehensive suite of biological biofilm eradication technical services.
Biofilms rely heavily on an extracellular polymeric substance (EPS) matrix for structural integrity, shielding embedded sessile bacterial communities from antimicrobial agents and environmental stresses. Conventional approaches often struggle to fully dismantle mature biofilm architecture. To address this research bottleneck, CD BioSciences provides biological biofilm matrix degradation services, using biologically based approaches to disrupt or degrade the extracellular matrix of surface-associated biofilms.
A core technical solution within the portfolio is EPS removal using enzymatic detergents. The enzyme mixture is designed to degrade multiple components of the EPS matrix, including proteins, extracellular DNA, and polysaccharide-associated structures. Once the protective EPS framework is broken down, inter‑cellular and cell‑surface adhesion forces decline, biofilm-associated cells may detach or disperse, and embedded microbial cells become far more susceptible to antibiotic treatment.
This service covers an extensive panel of target bacteria, including multiple Gram‑negative strains such as Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Gram‑positive pathogens including Staphylococcus aureus, Staphyloc0occus epidermidis, Enterococcus faecalis, and Streptococcus mutans. Researchers can access custom‑tailored project schemes based on their experimental objectives, bacterial strains, and study design requirements.
As a one‑stop biofilm service provider, CD BioSciences provides comprehensive experimental data and project deliverables. Deliverables consist of quality-control documentation, raw experimental datasets, data analysis results, and additional experimental documentation, where applicable. Researchers can select appropriate biofilm analytical workflows, while in‑house technical experts develop custom service plans for individual research programs.
With years of experience in biofilm detection and intervention research, CD BioSciences supports standalone assays as well as end‑to‑end project support. The reliable technical services aim to accelerate drug discovery workflows for biofilm‑focused research clients worldwide.
About CD BioSciences
CD BioSciences is a specialized provider of biofilm research services and technical solutions for the global life science research community. With experienced scientific personnel, specialized technical capabilities, and integrated research workflows, CD BioSciences supports researchers with integrated technical services spanning experimental design, biofilm characterization, intervention studies, and data analysis.
Media Contact
Company Name: CD BioSciences
Contact Person: Kikiwi Davis
Email: Send Email
Country: United States
Website: https://www.biofilma.com/
